drugset / Trial / NCT02241629

Levo Phencynonate Hydrochloride for the Prevention of Seasickness

NCT02241629 ↗

Phase 2 Completed 180 enrolled Sihuan Pharmaceutical Holdings Group Ltd.
RandomizedParallel-groupTriple-blindPrevention

Summary

A double-blind, randomized, placebo controlled, multicenter, dose-finding phaseⅡclinical superiority study.

Timeline

Start
2014-08
Primary completion
2014-12
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Levophencynonate Unknown 1 mg —
Subject Levophencynonate Unknown 2 mg —

Indications